pAAV-pCAG-Floxed-FlpO-2A-H2BV5c.o.,rev.-WPRE (e.g. AAV-flex-FlpO-H2B-V5) - Aligning Science Across Parkinson's

Research Community
Research Community

ASAP supports three programs and serves as a member of multiple consortia to advance research for the benefit of the global Parkinson’s disease community.
Explore
Highlights
Highlights

ASAP shares the impact that our initiative, network, and supported programs have had on providing new insights into Parkinson’s disease. Discover news, interviews, awards, and annual impact.
Explore
Open Science
Open Science

ASAP is dedicated to facilitating a research environment where meaningful collaboration, research-enabling resources, and data sharing provides the answers we need to understand, diagnose, and treat Parkinson’s disease. Discover our open science philosophy.
Explore
Tools & Resources
Tools & Resources

ASAP is committed to developing and openly sharing research outputs, including data, code, protocols, and key lab materials, to help the scientific community build upon existing work.
Explore

Description

Plasmid is CAG-driven, Cre-dependent FlpO recombinase for H2B-V5.

Tags

AAV (Adenoassociated Virus)
Plasmids

Team

Team Surmeier

Program

Collaborative Research Network

Theme

Circuitry and Brain-Body Interactions

Meet the Authors

Antonio Falasconi, MD

Key Personnel: Team Surmeier,

Biozentrum, University of Basel
Harsh Kanodia, MSc

Key Personnel: Team Surmeier,

Friedrich Miescher Institute
Silvia Arber, PhD

Co-PI (Core Leadership): Team Surmeier,

Friedrich Miescher Institute